ATE283709T1 - Implantierbare partikel zur erhöhung des gewebevolumens und zur behandlung von gastroösophagalreflux, inkontinenz und hautfalten - Google Patents
Implantierbare partikel zur erhöhung des gewebevolumens und zur behandlung von gastroösophagalreflux, inkontinenz und hautfaltenInfo
- Publication number
- ATE283709T1 ATE283709T1 AT99909789T AT99909789T ATE283709T1 AT E283709 T1 ATE283709 T1 AT E283709T1 AT 99909789 T AT99909789 T AT 99909789T AT 99909789 T AT99909789 T AT 99909789T AT E283709 T1 ATE283709 T1 AT E283709T1
- Authority
- AT
- Austria
- Prior art keywords
- incontinence
- treat
- skin wrinkles
- tissue volume
- increase tissue
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
- A61K47/6921—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a particulate, a powder, an adsorbate, a bead or a sphere
- A61K47/6927—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a particulate, a powder, an adsorbate, a bead or a sphere the form being a solid microparticle having no hollow or gas-filled cores
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/04—X-ray contrast preparations
- A61K49/0433—X-ray contrast preparations containing an organic halogenated X-ray contrast-enhancing agent
- A61K49/0442—Polymeric X-ray contrast-enhancing agent comprising a halogenated group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/04—X-ray contrast preparations
- A61K49/0433—X-ray contrast preparations containing an organic halogenated X-ray contrast-enhancing agent
- A61K49/0447—Physical forms of mixtures of two different X-ray contrast-enhancing agents, containing at least one X-ray contrast-enhancing agent which is a halogenated organic compound
- A61K49/0476—Particles, beads, capsules, spheres
- A61K49/048—Microparticles, microbeads, microcapsules, microspheres, i.e. having a size or diameter higher or equal to 1 micrometer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Urology & Nephrology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Reproductive Health (AREA)
- Gynecology & Obstetrics (AREA)
- Diabetes (AREA)
- Hospice & Palliative Care (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Dermatology (AREA)
- Child & Adolescent Psychology (AREA)
- Otolaryngology (AREA)
- Materials For Medical Uses (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Cosmetics (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US7716698P | 1998-03-06 | 1998-03-06 | |
PCT/US1999/004689 WO1999044643A1 (en) | 1998-03-06 | 1999-03-04 | Implantable particles for tissue bulking and the treatment of gastroesophageal reflux disease, urinary incontinence, and skin wrinkles |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE283709T1 true ATE283709T1 (de) | 2004-12-15 |
Family
ID=22136460
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT99909789T ATE283709T1 (de) | 1998-03-06 | 1999-03-04 | Implantierbare partikel zur erhöhung des gewebevolumens und zur behandlung von gastroösophagalreflux, inkontinenz und hautfalten |
Country Status (10)
Country | Link |
---|---|
US (2) | US6335028B1 (de) |
EP (1) | EP1059943B1 (de) |
JP (2) | JP5095049B2 (de) |
CN (2) | CN1714783A (de) |
AT (1) | ATE283709T1 (de) |
AU (1) | AU742786B2 (de) |
CA (1) | CA2322954C (de) |
DE (1) | DE69922352T2 (de) |
HK (1) | HK1035318A1 (de) |
WO (1) | WO1999044643A1 (de) |
Families Citing this family (87)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE69534233T2 (de) * | 1994-09-16 | 2005-10-27 | Ethicon Endo-Surgery, Inc., Cincinnati | Vorrichtungen zum bestimmen und markieren von gewebe |
US6270464B1 (en) * | 1998-06-22 | 2001-08-07 | Artemis Medical, Inc. | Biopsy localization method and device |
US6660301B1 (en) * | 1998-03-06 | 2003-12-09 | Biosphere Medical, Inc. | Injectable microspheres for dermal augmentation and tissue bulking |
AU742786B2 (en) * | 1998-03-06 | 2002-01-10 | Biosphere Medical, Inc. | Implantable particles for tissue bulking and the treatment of gastroesophageal reflux disease, urinary incontinence, and skin wrinkles |
US6866842B1 (en) | 1998-05-01 | 2005-03-15 | University Of Pittsburgh | Muscle-derived cells (MDCs) for treating muscle-or bone-related injury or dysfunction |
US7115417B1 (en) | 1998-05-01 | 2006-10-03 | Chancellor Michael B | Soft tissue and bone augmentation and bulking utilizing muscle-derived progenito compositions, and treatments thereof |
US20020058882A1 (en) * | 1998-06-22 | 2002-05-16 | Artemis Medical, Incorporated | Biopsy localization method and device |
US6591838B2 (en) * | 1998-07-06 | 2003-07-15 | Scimed Life Systems, Inc. | Implant system and method for bulking tissue |
FR2784580B1 (fr) | 1998-10-16 | 2004-06-25 | Biosepra Inc | Microspheres de polyvinyl-alcool et procedes de fabrication de celles-ci |
US6595910B2 (en) * | 1998-12-11 | 2003-07-22 | Scimed Life Systems, Inc. | Method for treating fecal incontinence |
US6251064B1 (en) * | 1998-12-11 | 2001-06-26 | Enteric Medical Technologies, Inc. | Method for creating valve-like mechanism in natural body passageway |
US7132582B2 (en) * | 2003-05-30 | 2006-11-07 | Council Of Scientific And Industrial Research | Catalytic process for the preparation of isolongifolene |
US6238335B1 (en) * | 1998-12-11 | 2001-05-29 | Enteric Medical Technologies, Inc. | Method for treating gastroesophageal reflux disease and apparatus for use therewith |
US6358197B1 (en) * | 1999-08-13 | 2002-03-19 | Enteric Medical Technologies, Inc. | Apparatus for forming implants in gastrointestinal tract and kit for use therewith |
US20080299213A2 (en) * | 1999-11-05 | 2008-12-04 | Donald Kleinsek | Augmentation and repair of spincter defects with cells including adipocytic cells |
US6547776B1 (en) * | 2000-01-03 | 2003-04-15 | Curon Medical, Inc. | Systems and methods for treating tissue in the crura |
EP1263803B1 (de) | 2000-03-13 | 2007-09-19 | BioCure, Inc. | Embolische zusammensetzungen |
US6652883B2 (en) | 2000-03-13 | 2003-11-25 | Biocure, Inc. | Tissue bulking and coating compositions |
WO2001068722A1 (en) | 2000-03-13 | 2001-09-20 | Biocure, Inc. | Hydrogel biomedical articles |
EP1267955B1 (de) * | 2000-03-20 | 2006-05-31 | Biosphere Medical, Inc. | Injizierbare mikrokügelchen für den gewebeaufbau |
AU2001249221A1 (en) | 2000-03-20 | 2001-10-03 | Biosphere Medical, Inc. | Injectable and swellable microspheres for tissue bulking |
US6436424B1 (en) | 2000-03-20 | 2002-08-20 | Biosphere Medical, Inc. | Injectable and swellable microspheres for dermal augmentation |
US7338657B2 (en) | 2001-03-15 | 2008-03-04 | Biosphere Medical, Inc. | Injectable microspheres for tissue construction |
EP1656957B1 (de) | 2000-03-20 | 2015-06-03 | Biosphere Medical, Inc. | Injizierbare Mikrosphären zur Gewebekonstruktion |
CN1430505A (zh) * | 2000-03-24 | 2003-07-16 | 生物领域医疗公司 | 用于主动栓塞术的微球体 |
US20030212022A1 (en) * | 2001-03-23 | 2003-11-13 | Jean-Marie Vogel | Compositions and methods for gene therapy |
AU5159901A (en) * | 2000-04-14 | 2001-10-30 | Univ Pittsburgh | Soft tissue and bone augmentation and bulking utilizing muscle-derived progenitor cells, compositions and treatments thereof |
US6355275B1 (en) | 2000-06-23 | 2002-03-12 | Carbon Medical Technologies, Inc. | Embolization using carbon coated microparticles |
US6394965B1 (en) | 2000-08-15 | 2002-05-28 | Carbon Medical Technologies, Inc. | Tissue marking using biocompatible microparticles |
MY130475A (en) | 2000-08-25 | 2007-06-29 | Contura As | Polyacrylamide hydrogel and its use as an endoprosthesis |
US7186419B2 (en) * | 2000-08-25 | 2007-03-06 | Contura Sa | Polyacrylamide hydrogel for arthritis |
US20090130066A1 (en) * | 2000-11-06 | 2009-05-21 | Gerigene Medical Corporation | Augmentation and repair of sphincter defects with cells including muscle cells |
US9080146B2 (en) * | 2001-01-11 | 2015-07-14 | Celonova Biosciences, Inc. | Substrates containing polyphosphazene as matrices and substrates containing polyphosphazene with a micro-structured surface |
US6878384B2 (en) * | 2001-03-13 | 2005-04-12 | Microvention, Inc. | Hydrogels that undergo volumetric expansion in response to changes in their environment and their methods of manufacture and use |
US20030078466A1 (en) * | 2001-08-31 | 2003-04-24 | Silverman David E. | Method for treating muscle in wall and apparatus for same |
US8685427B2 (en) | 2002-07-31 | 2014-04-01 | Boston Scientific Scimed, Inc. | Controlled drug delivery |
US8133501B2 (en) * | 2002-02-08 | 2012-03-13 | Boston Scientific Scimed, Inc. | Implantable or insertable medical devices for controlled drug delivery |
US20080226723A1 (en) * | 2002-07-05 | 2008-09-18 | Celonova Biosciences, Inc. | Loadable Polymeric Particles for Therapeutic Use in Erectile Dysfunction and Methods of Preparing and Using the Same |
US8920826B2 (en) * | 2002-07-31 | 2014-12-30 | Boston Scientific Scimed, Inc. | Medical imaging reference devices |
EP1578281A2 (de) * | 2002-11-25 | 2005-09-28 | Boston Scientific Limited | Injektionsvorrichtung zur behandlung eines säugetier |
DE602004029349D1 (de) * | 2003-04-25 | 2010-11-11 | Univ Pittsburgh | Von muskeln stammende zellen (mdcs) zur förderung und verbesserung der nervenreparatur und -regeneration |
AU2003242464A1 (en) * | 2003-06-18 | 2005-01-04 | Hokkaido Technology Licensing Office Co., Ltd. | Material for cell adhesion and proliferation |
US8092527B2 (en) * | 2003-09-03 | 2012-01-10 | Brennan William A | System and method for breast augmentation |
US7169180B2 (en) * | 2003-09-03 | 2007-01-30 | Brennan William A | System and method for breast augmentation |
US8057533B2 (en) | 2003-10-29 | 2011-11-15 | Boston Scientific Scimed, Inc. | Apparatus with visual marker for guiding deployment of implantable prosthesis |
US7585271B2 (en) * | 2003-11-01 | 2009-09-08 | Thd Spa | Implantable devices and methods for treating urinary incontinence |
EP1691852A2 (de) * | 2003-11-10 | 2006-08-23 | Angiotech International AG | Medizinsche implantate und fibroseinduzierende mittel |
WO2005118060A2 (en) * | 2004-04-30 | 2005-12-15 | Boston Scientific Limited | Apparatus with partially insulated needle for measuring tissue impedance and method using same |
US7442389B2 (en) * | 2004-08-20 | 2008-10-28 | Artes Medical, Inc. | Methods of administering microparticles combined with autologous body components |
WO2006026731A1 (en) | 2004-08-30 | 2006-03-09 | Spineovations, Inc. | Method of treating spinal internal disk derangement |
WO2006026554A1 (en) * | 2004-08-30 | 2006-03-09 | Neville Alleyne | Method of using an implant for treatment of ligaments and tendons |
US20060073208A1 (en) * | 2004-10-01 | 2006-04-06 | Allergan, Inc. | Cosmetic neurotoxin compositions and methods |
US9107850B2 (en) * | 2004-10-25 | 2015-08-18 | Celonova Biosciences, Inc. | Color-coded and sized loadable polymeric particles for therapeutic and/or diagnostic applications and methods of preparing and using the same |
US20210299056A9 (en) | 2004-10-25 | 2021-09-30 | Varian Medical Systems, Inc. | Color-Coded Polymeric Particles of Predetermined Size for Therapeutic and/or Diagnostic Applications and Related Methods |
US9114162B2 (en) | 2004-10-25 | 2015-08-25 | Celonova Biosciences, Inc. | Loadable polymeric particles for enhanced imaging in clinical applications and methods of preparing and using the same |
WO2006046155A2 (en) | 2004-10-25 | 2006-05-04 | Polyzenix Gmbh | Loadable polyphosphazene-comprising particles for therapeutic and/or diagnostic applications and methods of preparing and using the same |
US7305993B2 (en) * | 2004-10-26 | 2007-12-11 | Medtronic, Inc. | Implantation of tissue bulking devices |
US7942873B2 (en) * | 2005-03-25 | 2011-05-17 | Angiodynamics, Inc. | Cavity ablation apparatus and method |
CN104815331A (zh) | 2005-05-09 | 2015-08-05 | 生物领域医疗公司 | 使用微球和非离子型造影剂的组合物和方法 |
US8263109B2 (en) | 2005-05-09 | 2012-09-11 | Boston Scientific Scimed, Inc. | Injectable bulking compositions |
US7862552B2 (en) * | 2005-05-09 | 2011-01-04 | Boston Scientific Scimed, Inc. | Medical devices for treating urological and uterine conditions |
EP1948096A2 (de) * | 2005-10-26 | 2008-07-30 | BioCure, Inc. | Hydrogel-bandscheibenimplantate mit quellbaren artikeln |
WO2007090127A2 (en) * | 2006-01-30 | 2007-08-09 | Surgica Corporation | Compressible intravascular embolization particles and related methods and delivery systems |
WO2007090130A2 (en) * | 2006-01-30 | 2007-08-09 | Surgica Corporation | Porous intravascular embolization particles and related methods |
AU2007232187A1 (en) * | 2006-03-31 | 2007-10-11 | Csir | Bulking of soft tissue |
WO2008051864A2 (en) * | 2006-10-24 | 2008-05-02 | Neville Alleyne | Method of treating spinal internal disk derangement |
US20080299172A1 (en) * | 2007-06-04 | 2008-12-04 | Stuart Young | Tissue repair implant |
US20090110738A1 (en) * | 2007-10-26 | 2009-04-30 | Celonova Biosciences, Inc. | Loadable Polymeric Particles for Cosmetic and Reconstructive Tissue Augmentation Applications and Methods of Preparing and Using the Same |
US20090111763A1 (en) * | 2007-10-26 | 2009-04-30 | Celonova Biosciences, Inc. | Loadable polymeric particles for bone augmentation and methods of preparing and using the same |
US20090110731A1 (en) * | 2007-10-30 | 2009-04-30 | Celonova Biosciences, Inc. | Loadable Polymeric Microparticles for Therapeutic Use in Alopecia and Methods of Preparing and Using the Same |
US8469961B2 (en) | 2008-03-05 | 2013-06-25 | Neville Alleyne | Methods and compositions for minimally invasive capsular augmentation of canine coxofemoral joints |
US20100004700A1 (en) * | 2008-03-05 | 2010-01-07 | Neville Alleyne | Method of treating tissue with a suspenson of tricalcium hydroxyapatite microspheres |
US20110009520A1 (en) * | 2008-03-20 | 2011-01-13 | Figuly Garret D | Dimensionally stable, shaped articles comprised of dried, aggregated, water-swellable hydrogel microspheres and method of making same |
US20110212179A1 (en) * | 2008-10-30 | 2011-09-01 | David Liu | Micro-spherical porous biocompatible scaffolds and methods and apparatus for fabricating same |
JP2012513462A (ja) * | 2008-12-23 | 2012-06-14 | ボード・オブ・リージェンツ・オブ・ザ・ユニバーシティ・オブ・テキサス・システム | 炎症標的化粒子 |
US8657859B2 (en) | 2009-12-16 | 2014-02-25 | Advanced Veterinary Solutions | Implant for promoting stability of the canine stifle joint |
EP2351779B1 (de) | 2010-01-27 | 2019-04-24 | Biosphere Medical, Inc. | Mikrokügelchen und Verfahren zur Herstellung der Mikrokügelchen |
US9232805B2 (en) | 2010-06-29 | 2016-01-12 | Biocure, Inc. | In-situ forming hydrogel wound dressings containing antimicrobial agents |
JP6382854B2 (ja) | 2013-03-04 | 2018-08-29 | ダーメル,リミティド ライアビリティ カンパニー ディー/ビー/エー エターノジェン,リミティド ライアビリティ カンパニー | InSituで重合する注射可能なコラーゲン組成物 |
WO2014159759A1 (en) | 2013-03-13 | 2014-10-02 | Biosphere Medical, Inc. | Compositions and associated methods for radioisotope-binding microparticles |
CN105814120B (zh) | 2013-09-19 | 2019-07-05 | 泰尔茂株式会社 | 聚合物颗粒 |
AU2014321278B2 (en) | 2013-09-19 | 2016-11-10 | Microvention, Inc. | Polymer films |
WO2015070094A1 (en) | 2013-11-08 | 2015-05-14 | Microvention, Inc. | Polymer particles |
AU2016206507B2 (en) | 2015-01-16 | 2020-12-17 | Spineovations, Inc. | Method of treating spinal disk |
WO2016154592A1 (en) | 2015-03-26 | 2016-09-29 | Microvention, Inc. | Embiolic particles |
US10137082B2 (en) * | 2016-08-22 | 2018-11-27 | Washington University | Hydrogel microparticle scaffold with gradients of degradability and methods thereof |
KR102241904B1 (ko) | 2016-09-28 | 2021-04-16 | 테루모 가부시키가이샤 | 중합체 입자 |
Family Cites Families (25)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3919411A (en) | 1972-01-31 | 1975-11-11 | Bayvet Corp | Injectable adjuvant and compositions including such adjuvant |
US4197846A (en) | 1974-10-09 | 1980-04-15 | Louis Bucalo | Method for structure for situating in a living body agents for treating the body |
FR2378808A1 (fr) | 1977-01-28 | 1978-08-25 | Mar Pha Etu Expl Marques | Nouveaux copolymeres hydrophiles a base de n-(tris(hydroxy-methyl)methyl)acrylamide ou de n-(tris (hydroxymethyl)methyl)methacrylamide, leur preparation et leur emploi dans les techniques de separation |
FR2482112B1 (fr) | 1980-05-09 | 1985-06-07 | Pharmindustrie | Nouveaux copolymeres hydrophiles a base de n-(tris (hydroxymethyl) methyl) acrylamide, procedes pour leur preparation, gels aqueux desdits copolymeres et leur utilisation comme echangeurs d'ions |
FI75816C (fi) | 1981-02-06 | 1988-08-08 | Ucb Sa | Foerfarande foer framstaellning av terapeutiskt aktiv 2-/4-(difenylmetyl)-1-piperazinyl/-aettiksyror eller dess amid. |
US4413070A (en) | 1981-03-30 | 1983-11-01 | California Institute Of Technology | Polyacrolein microspheres |
US4622362A (en) | 1981-03-30 | 1986-11-11 | California Institute Of Technology | Polyacrolein microspheres |
US4500658A (en) | 1983-06-06 | 1985-02-19 | Austenal International, Inc. | Radiopaque acrylic resin |
US4786555A (en) | 1983-10-27 | 1988-11-22 | E. I. Du Pont De Nemours And Company | Support particles coated with or particles of precursors for or of biologically active glass |
US4803075A (en) | 1986-06-25 | 1989-02-07 | Collagen Corporation | Injectable implant composition having improved intrudability |
US5510418A (en) | 1988-11-21 | 1996-04-23 | Collagen Corporation | Glycosaminoglycan-synthetic polymer conjugates |
US5162430A (en) | 1988-11-21 | 1992-11-10 | Collagen Corporation | Collagen-polymer conjugates |
DE3841401A1 (de) | 1988-12-08 | 1990-06-13 | Martin Lemperle | Alloplastisches implantat |
US5007940A (en) | 1989-06-09 | 1991-04-16 | American Medical Systems, Inc. | Injectable polymeric bodies |
FR2676927B1 (fr) | 1991-05-29 | 1995-06-23 | Ibf | Microspheres utilisables pour les occlusions vasculaires therapeutiques et solutions injectables les contenant. |
JPH0656676A (ja) | 1992-08-05 | 1994-03-01 | Hori Shinichi | 血管塞栓用懸濁液 |
US5578709A (en) | 1993-03-09 | 1996-11-26 | Middlesex Sciences, Inc. | Macromolecular microparticles and methods of production |
DE784487T1 (de) | 1993-03-19 | 1999-11-04 | Q-Med Ab, Uppsala | Ein präparat und ein verfahren zur gewebevermehrung |
GB2281861B (en) * | 1993-09-21 | 1997-08-20 | Johnson & Johnson Medical | Bioabsorbable wound implant materials containing microspheres |
US5451406A (en) | 1994-07-14 | 1995-09-19 | Advanced Uroscience, Inc. | Tissue injectable composition and method of use |
JPH11507679A (ja) * | 1995-06-06 | 1999-07-06 | シー.アール.バード,インコーポレイティド | 水溶性ポリマーの粒子の水性分散液の製造法および得られた粒子 |
US5792478A (en) * | 1996-07-08 | 1998-08-11 | Advanced Uro Science | Tissue injectable composition and method of use |
CA2219605C (en) * | 1996-10-31 | 2002-02-05 | Deepa Ashok Khambe | Method of stimulating gastrointestinal motility with ellagic acid |
US6224893B1 (en) * | 1997-04-11 | 2001-05-01 | Massachusetts Institute Of Technology | Semi-interpenetrating or interpenetrating polymer networks for drug delivery and tissue engineering |
AU742786B2 (en) * | 1998-03-06 | 2002-01-10 | Biosphere Medical, Inc. | Implantable particles for tissue bulking and the treatment of gastroesophageal reflux disease, urinary incontinence, and skin wrinkles |
-
1999
- 1999-03-04 AU AU28916/99A patent/AU742786B2/en not_active Ceased
- 1999-03-04 CN CNA2004100642974A patent/CN1714783A/zh active Pending
- 1999-03-04 AT AT99909789T patent/ATE283709T1/de not_active IP Right Cessation
- 1999-03-04 DE DE69922352T patent/DE69922352T2/de not_active Expired - Lifetime
- 1999-03-04 CN CNB99805884XA patent/CN100457188C/zh not_active Expired - Fee Related
- 1999-03-04 JP JP2000534243A patent/JP5095049B2/ja not_active Expired - Lifetime
- 1999-03-04 EP EP99909789A patent/EP1059943B1/de not_active Expired - Lifetime
- 1999-03-04 CA CA2322954A patent/CA2322954C/en not_active Expired - Fee Related
- 1999-03-04 WO PCT/US1999/004689 patent/WO1999044643A1/en active IP Right Grant
- 1999-03-05 US US09/263,773 patent/US6335028B1/en not_active Expired - Fee Related
-
2001
- 2001-06-20 HK HK01104281A patent/HK1035318A1/xx not_active IP Right Cessation
- 2001-12-28 US US10/029,294 patent/US7060298B2/en not_active Expired - Lifetime
-
2010
- 2010-07-05 JP JP2010152667A patent/JP2010248233A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
CA2322954C (en) | 2011-06-07 |
EP1059943B1 (de) | 2004-12-01 |
US7060298B2 (en) | 2006-06-13 |
DE69922352T2 (de) | 2005-12-15 |
AU742786B2 (en) | 2002-01-10 |
AU2891699A (en) | 1999-09-20 |
US20020068089A1 (en) | 2002-06-06 |
JP5095049B2 (ja) | 2012-12-12 |
CN100457188C (zh) | 2009-02-04 |
CN1299291A (zh) | 2001-06-13 |
CA2322954A1 (en) | 1999-09-10 |
WO1999044643A1 (en) | 1999-09-10 |
JP2010248233A (ja) | 2010-11-04 |
CN1714783A (zh) | 2006-01-04 |
JP2002505308A (ja) | 2002-02-19 |
US6335028B1 (en) | 2002-01-01 |
HK1035318A1 (en) | 2001-11-23 |
EP1059943A1 (de) | 2000-12-20 |
DE69922352D1 (de) | 2005-01-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE283709T1 (de) | Implantierbare partikel zur erhöhung des gewebevolumens und zur behandlung von gastroösophagalreflux, inkontinenz und hautfalten | |
DE60023043T2 (de) | (S,S)-Reboxetin zur Behandlung von Inkontinenz | |
DE60037394D1 (de) | VERWENDUNG VON p53 INHIBITOREN ZUR BEHANDLUNG VON NEBENERSCHEINUNGEN BEI DER KREBSTHERAPIE | |
DE60236413D1 (de) | Inhibitoren von hmgb1 zur behandlung von gewebekrankheiten | |
ATE331534T1 (de) | Anwendung von zielgerichtetem radium 223 für palliative und therapeutische behandlung von knochenkrebs | |
DE60028863D1 (de) | Elektrochirurgisches Handstück zur Behandlung von Gewebe | |
DE69829921D1 (de) | Vorrichtung zur Behandlung von Körpergewebe | |
HK1043947A1 (en) | Use of biochemical substances in the manufacture of a medicament for preventing and treating health conditions caused by constriction of smooth musclecells in organs of the human body | |
DE60131569D1 (de) | Genetisch veränderter herpes virus für die behandlung von herz- und gefässerkrankungen | |
WO2002007749A3 (en) | Device providing regulated growth factor delivery for the regeneration of peripheral nerves | |
HK1047707A1 (zh) | (+)-曲馬朵、o-去甲曲馬朵或(+)-o-去甲曲馬朵、o-去甲-n-單-去甲-曲馬朵或(+)-o-去甲-n-單-去甲-曲馬朵治療尿失禁的用途 | |
FR12C0058I2 (fr) | Medicament pour traiter des maladies de peau virales et des maladies tumorales | |
DE60231246D1 (de) | Superoxiddismutas-mimetika zur behandlung von augenerkrankungen | |
TR200501763T2 (tr) | Tedavi ve ilaç tarama yöntemleri | |
WO2004091646A3 (en) | Use of slurp-1 for treating diseases related to acetylcholine receptors dysfunction | |
DE60017174D1 (de) | Rivastigmine zur behandlung von augenerkrankungen | |
WO1999016406A3 (en) | Therapeutic method | |
WO2005062942A3 (en) | Novel oligonucleotides and treating cardiac disorders by using the same | |
IL153426A0 (en) | Method of treating peripheral vascular diseases, peripheral neuropathies, and autonomic neuropathies | |
ATE341323T1 (de) | Verwendung von darifenacin zur behandlung des harndrangs | |
DE69813354D1 (de) | Mittel zur Behandlung von Herzkrankheiten | |
RU2289443C2 (ru) | Способ лечения болевого синдрома при распространенном остеохондрозе | |
Watson | Electrical stimulation for enhanced wound healing | |
HK1072005A1 (en) | Modulation of smooth muscle cell proliferation | |
Mayrovitz | Electromagnetic linkages in soft tissue wound healing |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |